| abstract |
The present invention has an α 1 -adrenergic receptor blocking action, wherein: Indolin compound, prodrug thereof, or pharmacologically acceptable salts thereof and pharmacologically acceptable solvates thereof, which are represented by In the dissolution test of the present invention, an oral solid drug for treating urination disorder is prepared so that 85% dissolution time is within 60 minutes. |